Cargando…
Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo
We have previously described novel histone acetyltransferase (HAT) inhibitors that block neuroblastoma cell growth in vitro. Here we show that two selected pyridoisothiazolone HAT inhibitors, PU139 and PU141, induce cellular histone hypoacetylation and inhibit growth of several neoplastic cell lines...
Autores principales: | Gajer, J M, Furdas, S D, Gründer, A, Gothwal, M, Heinicke, U, Keller, K, Colland, F, Fulda, S, Pahl, H L, Fichtner, I, Sippl, W, Jung, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338425/ https://www.ncbi.nlm.nih.gov/pubmed/25664930 http://dx.doi.org/10.1038/oncsis.2014.51 |
Ejemplares similares
-
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020) -
Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors
por: Dahlin, Jayme L., et al.
Publicado: (2017) -
Ex Vivo Expansion of Human Hematopoietic Stem Cells by Garcinol, a Potent Inhibitor of Histone Acetyltransferase
por: Nishino, Taito, et al.
Publicado: (2011) -
Rational design and validation of a Tip60 histone acetyltransferase inhibitor
por: Gao, Chunxia, et al.
Publicado: (2014) -
IRF5 is elevated in childhood-onset SLE and regulated by histone acetyltransferase and histone deacetylase inhibitors
por: Shu, Jin, et al.
Publicado: (2017)